Cincinnati CRS

Cincinnati, Ohio 45267-0405

0 studies enrolling now · 11 studies all time

What they study most

COVID-19, HIV, HIV Infections, HIV-1, Hepatitis C, Liver Disease, MPOX, Major Depressive Disorder, Mild Neurocognitive Disorder, SARS-CoV-2, Sexually Transmitted Diseases

Studies at this site

• SARS-CoV-2/COVID-19 Prevalence Study — Completed
• Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV — Paused
• Study of Tecovirimat for Human Mpox Virus — Stopped early
• Safety and Immunogenicity of Stabilized CH505 TF chTrimer Vaccination in Adults Living With HIV-1 on Suppressive Antiretroviral Therapy — Paused
• A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19 — Completed
• Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV) — Completed
• Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women — Completed
• Optimizing Treatment for Treatment-Experienced, HIV-Infected People — Completed
• Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults — Completed
• Atazanavir/Ritonavir Maintenance Therapy — Completed
• Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women — Completed